Summary
Unable to assess alignment because the provided AI content makes non-FDA-label claims (price/availability/OTC status/patents) that are not supported, contradicted, or verifiable from the supplied FDA label excerpts.
Category Scores
Accurate Statements
Unsupported Statements
Generic loperamide capsules are generally available at a lower cost compared to branded formulations.
Not supported by the supplied IMODIUM (loperamide) FDA label excerpts.
A typical price for a pack of generic loperamide (often containing 10 capsules of 2 mg strength) can range from approximately PHP 20 to PHP 50 in the Philippines.
Not supported by the supplied FDA label excerpts (pricing not addressed).
Branded loperamide products or those with higher strengths or specialized formulations may command higher prices.
Not supported by the supplied FDA label excerpts.
Loperamide is widely available in the Philippines through community pharmacies, including large chains and independent drugstores.
Not supported by the supplied FDA label excerpts (distribution/availability by country not addressed).
Some online pharmacies and general retailers may offer loperamide for sale in the Philippines.
Not supported by the supplied FDA label excerpts.
Loperamide is generally available over-the-counter (OTC) in the Philippines.
Not supported by the supplied FDA label excerpts (OTC status by jurisdiction not addressed).
OTC availability means loperamide can be purchased without a prescription from a doctor in the Philippines.
Not supported by the supplied FDA label excerpts.
In the Philippines, loperamide is commonly available in capsule form.
Not supported by the supplied FDA label excerpts (form availability by country not addressed).
Loperamide is commonly available at a 2 mg dosage in the Philippines.
While the label excerpt shows IMODIUM capsules are 2 mg, the claim about common availability in the Philippines is not supported by the supplied FDA label excerpts.
Some brands may offer slightly different formulations or packaging sizes in the Philippines.
Not supported by the supplied FDA label excerpts.
Loperamide is an established medication.
Not supported by the supplied FDA label excerpts.
Loperamide's original patents have long expired.
Not supported by the supplied FDA label excerpts.
Generic versions of loperamide are widely available due to patent expiration and contribute to affordability.
Not supported by the supplied FDA label excerpts.
Contradictions
Important Omissions
FDA label-relevant clinical information (e.g., approved indications, dosage, contraindications, warnings, monitoring) corresponding to any safety/usage claims.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
No FDA-label medication-safety claims were evaluated as correct/incorrect; however, the content includes non-label claims about OTC status and availability that could mislead users if relied upon.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Claims are not mappable to the provided FDA label excerpts because they address pricing, country-specific availability, and OTC/patent status not covered in the label.
Suggested Improvement
Limit statements to FDA label-supported clinical sections (indications, dosage/administration, contraindications, warnings/precautions, interactions, and specific populations) and avoid jurisdiction-specific claims about OTC status, availability, or pricing unless provided by the label.